Status:
RECRUITING
Understanding Chronic Lymphocytic Leukemia
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Chronic Lymphocytic Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemi...
Detailed Description
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemi...
Eligibility Criteria
Inclusion
- New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
- Any low grade lymphoproliferative disorder
- Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Exclusion
- \-
Key Trial Info
Start Date :
September 29 1999
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 29 2032
Estimated Enrollment :
2750 Patients enrolled
Trial Details
Trial ID
NCT04028531
Start Date
September 29 1999
End Date
September 29 2032
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115